Roche RHHBY announced today that the FDA has approved a label expansion of ophthalmology drug Susvimo (ranibizumab injection). The regulatory body approved the drug Susvimo for the treatment of ...

GSK (GSK) stock gains as FDA broadens the label for the company's asthma therapy Nucala l for COPD with an eosinophilic ...

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...

"In addition to the established efficacy of CAMZYOS, these meaningful updates to the label reinforce the strong ... which were adjusted to drug interactions. This provides physicians with greater ...

"Recently completed GMP stability assay testing of single-use ampoules containing ... treatments in an off-label fashion. Notably, there is no FDA approved drug to treat this debilitating condition.

An off-label prescription drug has been shown to help some non-verbal children with autism discover the ability to speak. The drug, leucovorin, is a prescription vitamin that functions similarly ...

The company said Tuesday it updated the prescribing label of the drug, Librela, to mention rare health problems that had been reported since its introduction in the U.S. in 2023.

If you sell, package or label naloxone kits in Canada ... medical devices with an active medical device licence have the inner labelling of each drug component (ampoule, vial, prefilled syringe or ...

Singulair binds to brain receptors affecting psychiatric functions Merck spinoff Organon confident in Singulair's safety profile FDA has no plan to update drug label based on new data Nov 22 ...